Table 1 The association between STC2 and osteosarcoma clinical pathological features
Parameters | STC2(%) | P Value | ||
|---|---|---|---|---|
- / + | ++ / +++ | |||
Gender | Â | Â | Â | |
| Â | Male | 11 (40.7) | 16 (59.3) | 0.555 |
Female | 8 (50.0) | 8 (50.0) | ||
Age | Â | Â | Â | |
|  | < 20 | 8 (40.0) | 12 (60.0) | 0.861 |
20 ~ 50 | 6 (46.2) | 7 (53.8) | ||
≥ 50 | 5 (50.0) | 5 (50.0) | ||
Neoadjuvant chemotherapy | Â | Â | Â | |
| Â | No | 13 (38.2) | 21 (61.8) | 0.127 |
Yes | 6 (66.7) | 3 (33.3) | ||
Tumor location | Â | Â | Â | |
| Â | Left limbs | 14 (56.0) | 11 (44.0) | 0.066 |
Right limbs | 5 (27.8) | 13 (72.2) | ||
Necrosis | Â | Â | Â | |
| Â | none | 12 (37.5) | 20 (62.5) | 0.319 |
< 10% | 2 (66.7) | 1 (33.3) | ||
≥ 10% | 5 (62.5) | 3 (37.5) | ||
Tumor recurrence | Â | Â | Â | |
| Â | No | 16 (57.1) | 12 (42.9) | 0.019 |
Yes | 3 (20.0) | 12 (80.0) | ||
Tumor Ki67 expression | Â | Â | Â | |
|  | < 14% | 12 (66.7) | 6 (33.3) | 0.012 |
≥ 14% | 7 (28.0) | 18 (72.0) | ||
Bone marrow affection | Â | Â | Â | |
| Â | No | 14 (45.2) | 17 (54.8) | 0.836 |
Yes | 5 (41.7) | 7 (58.3) | ||
Distal metastasis | Â | Â | Â | |
| Â | No | 15 (48.4) | 16 (51.6) | 0.373 |
Yes | 4 (33.3) | 8 (66.7) | ||